Voclosporin, also known as Luveniq, is a synthetic compound that belongs to the class of drugs called calcineurin inhibitors. It is primarily used as an immunosuppressant medication to prevent organ rejection in transplant patients. The chemical name of voclosporin is (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-1-methoxy-21,24,27-trimethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone hydrochloride. Its molecular formula is C62H111N11O12.HCl and its molecular weight is 1203.67 g/mol. The CAS number for voclosporin is 515814-01-4.
Top Ten Keywords from Google and Synonyms:
Synonyms:
Health Benefits of This Product: The primary health benefit of voclosporin is its ability to suppress the immune system, which helps prevent organ rejection in transplant patients. This medication works by inhibiting calcineurin, an enzyme responsible for activating T-cells in the immune system. By suppressing T-cell activity, voclosporin reduces the risk of the body rejecting a transplanted organ.
Potential Effects: Aside from its use as an immunosuppressant medication, voclosporin has shown potential in treating other conditions such as lupus nephritis, an autoimmune disease that affects the kidneys. Studies have shown that voclosporin can reduce proteinuria (the presence of excess protein in urine), which is a common symptom of lupus nephritis. Additionally, this drug may also help treat dry eye syndrome by reducing inflammation in the ocular surface.
Product Mechanism: The mechanism of action of voclosporin involves inhibiting calcineurin, an enzyme that plays a crucial role in T-cell activation. T-cells are white blood cells that play a vital role in the immune response by identifying and attacking foreign substances in the body. By suppressing calcineurin, voclosporin prevents T-cell activation and reduces the risk of organ rejection in transplant patients.
Safety: As with any medication, there are certain safety considerations when using voclosporin. One potential concern is the increased risk of infections due to the drug's effect on the immune system. Patients taking voclosporin should be monitored closely for signs of infection and treated promptly if necessary. Other possible side effects include high blood pressure, tremors, and changes in kidney function.
Side Effects: There are several potential side effects associated with the use of voclosporin. These include high blood pressure, tremors, headache, nausea, diarrhea, and constipation. In rare cases, this medication may also cause serious side effects such as liver damage or an increased risk of cancer.
Dosing Information: The dosing regimen for voclosporin varies depending on the specific condition being treated and the patient's individual needs. For organ transplant patients, the usual dose is 0.4 mg/kg twice daily, although this may be adjusted based on factors such as age, weight, and kidney function. For lupus nephritis, the recommended dose is 23.7 mg twice daily.
Conclusion: Overall, voclosporin is an important medication used to prevent organ rejection in transplant patients.
